Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cells

International Journal of Cancer

Volumn 115, Issue 4, 2005, Pages 511-518

  Boulanger, Emmanuelle ^a   Duprez, Renan ^a   Delabesse, Eric ^b   Gabarre, Jean ^c   Macintyre, Elizabeth ^b   Gessain, Antoine ^a  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

B cells; Clonality; Epstein Barr virus; Human herpesvirus 8; KSHV HHV 8; Primary effusion lymphoma

Indexed keywords

GENOMIC DNA; OLIGOCLONAL BAND; PARAPROTEIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; EPISOME; EPSTEIN BARR VIRUS; FEMALE; GENE INSERTION SEQUENCE; GENE REARRANGEMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LATENT VIRUS INFECTION; MALE; POLYMERASE CHAIN REACTION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING; SUPERINFECTION; TUMOR CELL;

ADULT; AGED; ANTIGENS, CD; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SARCOMA, KAPOSI;

EID: 18544373531     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20926     Document Type: Article

References (42)

1. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003;22:5108-21.
2. Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Path 2004;28:1401-16.
3. Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coins? Ann Rev Microbiol 2003;57:609-39.
4. Knowles DM. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin N Am 2003;17:785-820.
5. Horestein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 1997;90:1186-91.
6. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-56.
7. Komanduri KV, Luce JA, McGrath MS, Herndier BG, Ng VL. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J AIDS Hum Retrovirol 1996;13:215-26.
8. Boulanger E, Agbalika F, Maarek O, Daniel MT, Grollet L, Molina JM, Sigaux F, Oksenhendler E. A clinical, molecular and cytogenetic study of twelve cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. Hematol J 2001;2:172-9.
9. Ansari MQ, Dawson DB, Nador R, Rutherford C, Schneider NR, Latimer MJ, Picker L, Knowles DM, McKenna RW. Primary body cavity-based AIDS-related lymphomas. Am J Clin Path 1996;105:221-9.
10. Otsuki T, Kumar S, Ensoli B, Kingma DW, Yano T, Stetler-Stevenson M, Jaffe ES, Raffeld M. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996;10:1358-62.
11. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi sarcoma-associated herpes virus (HHV8). Proc Natl Acad Sci USA 1996;93:14862-7.
12. Judde JG, Lacoste V, Brière J, Kassa-Kelembho E, Clyti E, Couppié P, Buchrieser C, Tulliez M, Morvan J, Gessain A. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst 2000;92:729-36.
13. Drexler HG, Uphoff CC, Gaidano G, Carbone A. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia 1998;12:1507-17.
14. Morand P, Buisson M, Collandre H, Chanzy B, Genoulaz O, Bourgeat MJ, Pinel N, Leclercq P, Leroux D, Marechal V, Fritsch L, Ruigro R, et al. Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient. Leuk Lymphoma 1999;35:379-87.
15. Lacoste V, Judde JG, Bestetti G, Cadranel J, Antoine M, Valensi F, Delabesse E, Macintyre E, Gessain A. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/ HHV8 and EBV viruses. Leuk Lymphoma 2000;38:401-9.
16. Beishuizen A, Verhoeven MA, Mol EJ, Breit TM, Wolvers-Tettero IL, van Dongen JJ. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 1993;7:2045-53.
17. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
18. Gessain A, Brière J, Angelin-Duclos C, Valensi F, Merlé Béral H, Davi F, Nicola MA, Sudaka A, Fouchard N, Gabarre J, Troussard X, Dulmet E, et al. Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas. Leukemia 1997;11:266-72.
19. Lin JC, Lin SC, De BK, Chan WP, Evatt BL, Chan WC. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993;81:3372-81.
20. Landman-Parker J, Aubin J, Delabesse E, Tabone MD, Adam M, Millien C, Leboeuf D, Buzyn-Veil A, Dollfus C, Leverger G, Macintyre EA. Simplified strategies for minimal residual disease detection in B-cell precursor acute lymphoblastic leukemia. Br J Haematol 1996;95:281-90.
21. Delabesse E, Burtin ML, Millien C, Madonik A, Arnulf B, Beldjord K, Valensi F, Macintyre EA. Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations. Leukemia 2000;14:1143-52.
22. Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC. Primary effusion lymphoma and Kaposi's sarcoma in a cardiac transplant recipient. N Engl J Med 1998; 339:444-9.
23. Oksenhendler E, Clauvel JP, Jouveshomme S, Davi F, Mansour G. Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol 1998;57:266.
24. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders. Blood 1995;85:552-65.
25. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG. Kaposi sarcoma-associated herpesvirus infects monotypic (IgMlambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001;97:2130-6.
26. Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabeçadas J, Dong HY, Lee Harris N, Chan JKC, Rees JW, Dogan A, Isaacson PG. KSHV-and EBV-associated germinotropic lymphoproliferative disorder. Blood 2002;100:3415-8.
27. Matsushima AY, Strauchen JA, Lee G, Scigliano E, Hale EE, Weisse MT, Burstein D, Kamel O, Moore PS, Chang Y. Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Path 1999;23:1393-400.
28. Matolcsy A, Nador RG, Cesarman E, Knowles DM. Immunoglobulin Vh gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Path 1998;153:1609-14.
29. Hamoudi R, Diss TC, Oksenhendler E, Pan L, Carbone A, Ascoli V, Boshoff C, Isaacson P, Du MQ. Distinct cellular origins of primary effusion lymphoma with and without EBV infection. Leukemia Res 2004;28:333-8.
30. Deng JH, Zang YJ, Wang XP, Gao SJ. Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation. J Virol 2004;78:11108-20.
31. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. Lytic growth of Kaposi's sarcoma-associated herpes virus (human herpesvirus 8) in culture. Nat Med 1996;2:342-6.
32. Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C, Brett-Smith H, Haase AT. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 1999;73:4181-7.
33. Grundhoff A, Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 2004;113:124-36.
34. Yajima Y, Nonoyama M. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells. J Virol 1976;19:187-94.
35. Lidin BIM, Lamon EW, Cloud G, Soong SJ. Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines. Intervirology 1982;18:66-75.
36. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
37. Ascoli V, Sirianni MC, Mezzaroma I, Mastroianni CM, Vullo V, Andreoni M, Narciso P, Carnovale Scalzo C, Nardi F, Pistilli A, Lo Coco F. Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease. Ann Diagn Pathol 1999;3:357-63.
38. Monini P, Colombini S, Stürzl M, Goletti D, Cafaro A, Sgadari C, Butto S, Franco M, Leone P, Fais S, Leone P, Melucci-Vigo G, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 1999;93:4044-58.
39. Kliche S, Kremmer E, Hammerschmidt W, Koszinowski U, Haas J. Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8. J Virol 1998;72:8143-9.
40. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Sturzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpes-virus 8. J Virol 1997;71:7963-8.
41. Bryant-Greenwood P, Sorbara L, Filie AC, Little R, Yarchoan R, Wilson W, Raffeld M, Abati A. Infection of mesothelial cells with human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions. Mod Pathol 2003;16:145-53.
42. Bentley Lawrence J, Villnave CA, Singer RH. Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell 1988;52:51-61.